U.S. regulators approved the once-monthly injection to treat multiple sclerosis made by Biogen and AbbVie, but with a warning about the drug causing possible liver damage.
WSJ.com: US Business, Wall Street Journal: Business
Fri, 05/27/2016 - 7:41pm
U.S. regulators approved the once-monthly injection to treat multiple sclerosis made by Biogen and AbbVie, but with a warning about the drug causing possible liver damage.